InVitro Moves to Expand Market
- Share via
IRVINE — InVitro International, which makes products that test toxic levels in substances, said Tuesday that it will broaden its market by licensing a product from another Irvine drug company. InVitro will have the exclusive rights to market a Miragen Inc. product called Guardian DNA that helps to identify any living organism. Miragen will receive exclusive supply rights and future considerations. Financial details were not disclosed.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
